InvestorsHub Logo
Followers 0
Posts 167
Boards Moderated 0
Alias Born 03/28/2005

Re: DewDiligence post# 1664

Wednesday, 11/15/2006 4:30:03 PM

Wednesday, November 15, 2006 4:30:03 PM

Post# of 12660
<4. Changing the 9902b protocol to make Cox the primary endpoint supports the contention in item #3 above and makes 9902b the real pivotal study, in my view. (I.e., DNDN learned ex post facto that Cox gave a good result in 9902a and hence they are testing this Cox endpoint prospectively in 9902b. This is how things are supposed to be done.)>

This is a truly neat insight. I didn't know that Dendreon does research in biostatistics and is trying to get the FDA approval to sell a that to cure prostate cancer. I always thought that the endpoint for 9902b was survival. This Cox endpoint is something else. I guess we learn something new every day. Thanks Dew.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.